New Medical Centre Alexandria results, Q2 2024
Net profit, assets, equity and cash flow for Q2 2024, against the same period a year earlier, from the published financial statements.
Net profit29.82 millionEGP · +402.6% vs the same period a year earlier
Total assets366 millionEGP · +22.4% vs the same period a year earlier
Shareholders' equity221 millionEGP · +15.6% vs the same period a year earlier
Operating cash flow26.51 millionEGP · +788.2% vs the same period a year earlier
In short
- New Medical Centre Alexandria's net profit for Q2 2024 was about 29.82 million EGP, up +402.6% from 5.93 million EGP in Q2 2023.
- Total assets at the end of Q2 2024 were about 366 million EGP, and shareholders' equity about 221 million EGP.
- Operating cash flow for Q2 2024 was positive at 26.51 million EGP.
Key lines against the same period a year earlier
This periodQ2 2023Change
Net profit29.82 million5.93 million+402.6%
Gross profit120 million77.9 million+53.6%
Total assets366 million299 million+22.4%
Total liabilities145 million108 million+34.4%
Shareholders' equity221 million191 million+15.6%
Total liabilities and equity366 million299 million+22.4%
Operating cash flow26.51 million-3.85 million+788.2%
Investing cash flow-40.51 million-9.61 million−321.4%
Financing cash flow6.14 million——
Net change in cash-7.86 million-13.47 million+41.6%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
New Medical Centre Alexandria's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy